Rethinking classification of primary progressive and post-stroke aphasia


  • Classifying post-stroke aphasia (PSA) and primary progressive aphasia (PPA) in terms of graded variation in four key dimensions may be a more effective way of understanding where patients are situated in the spectrum of aphasia compared to the application of discrete subtype categories.

Why this matters

  • Aphasia, defined as an impaired ability to comprehend and formulate language, affects many aspects of linguistic communication including reading, auditory comprehension and expressive language.

  • Language impairments resulting from stroke (i.e. PSA) or neurodegeneration (i.e. PPA) have rarely been directly compared in the literature despite significant overlap in the conditions.

  • Categorical subtypes of PSA and PPA are often insufficient, with many patients falling into the “mixed” category, suggesting that a spectrum of subtypes exists rather than discrete, mutually exclusive subtypes.

  • Alternative, non-categorical classification systems making use of a ‘multidimensional space’ defined by dynamic scales of phonology, semantics, speech fluency and non-language cognitive skills, which have emerged in the field of PSA, may be a more effective way of meaningfully situating patients with aphasia including PPA.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.